Blumer Tech
  • Tech News
  • Business
  • Stock
  • Politics
Business

Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers

by June 28, 2024
June 28, 2024

The Biden administration on Wednesday said it will impose inflation penalties on 64 prescription drugs for the third quarter of this year, lowering costs for certain older Americans enrolled in Medicare. 

President Joe Biden has made lowering U.S. drug prices a key pillar of his health-care agenda and reelection platform for 2024. A provision of Biden’s Inflation Reduction Act requires drugmakers to pay rebates to Medicare, the federal health program for Americans over age 65, if they hike the price of a medication faster than the rate of inflation. 

It is separate from another provision under the law that allows Medicare to negotiate lower prescription drug prices with manufacturers. On average, Americans pay two to three times more than patients in other developed nations for prescription drugs, according to the Biden administration.

Some patients will pay a lower coinsurance rate for the 64 drugs covered under Wednesday’s announcement, which fall under Medicare Part B, for the period from July 1 to Sept. 30 “since each drug company raised prices faster than the rate of inflation,” according to a release from the administration.

Some Medicare Part B patients may save as much as $4,593 per day if they use those drugs during the quarter, the release added.  

More than 750,000 Medicare patients use the drugs each year, according to the release. The medications treat conditions such as cancer, certain infections and a bone disease called osteoporosis.

“Without the Inflation Reduction Act, seniors were completely exposed to Big Pharma’s price hikes. Not anymore,” Neera Tanden, White House domestic policy advisor, said in the release.

The Centers for Medicare & Medicaid Services plans to send the first invoices to drugmakers in 2025 for the rebates owed to the program.

In December, Biden released a list of 48 prescription drugs that would be subject to inflation penalties during the first quarter of 2024.

This post appeared first on NBC NEWS
previous post
YouTube is dominating the living room, forcing media companies to decide whether it’s friend or foe
next post
Walgreens plans store closures as CEO says consumers ‘stunned’ by prices

You may also like

FCC greenlights Paramount’s $8 billion merger with entertainment...

July 25, 2025

Microsoft’s Satya Nadella says job cuts have been...

July 25, 2025

UnitedHealth says it faces DOJ investigation over Medicare...

July 24, 2025

Uber will let women drivers and riders request...

July 24, 2025

Alphabet beats earnings expectations, raises spending forecast

July 24, 2025

UnitedHealth says it is facing DOJ investigation over...

July 24, 2025

Lawsuit says Clorox hackers got passwords simply by...

July 23, 2025

Businesses are cautiously spending on corporate travel as...

July 23, 2025

Credit card startup Imprint beats big banks for...

July 23, 2025

Orange juice importer says Brazil tariffs will squeeze...

July 22, 2025

    Join The Exclusive Subscription Today And Get Premium Articles For Free.


    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time.

    Tech News

    • Chart Mania – 23 ATR Move in QQQ – Metals Lead 2025 – XLV Oversold – XLU Breakout – ITB Moment of Truth

      July 26, 2025
    • FCC greenlights Paramount’s $8 billion merger with entertainment group Skydance

      July 25, 2025
    • Microsoft’s Satya Nadella says job cuts have been ‘weighing heavily’ on him

      July 25, 2025
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      July 25, 2025
    • Momentum Leaders Are Rotating — Here’s How to Find Them

      July 25, 2025
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 blumertech.com | All Rights Reserved

    Blumer Tech
    • Tech News
    • Business
    • Stock
    • Politics